Brain metastases in Japanese NSCLC patients: prognostic assessment and the use of osimertinib and immune checkpoint inhibitors—retrospective study

BACKGROUND: The Graded Prognostic Assessment for lung cancer using molecular markers (Lung-molGPA) has not been validated for use with Japanese non-small cell lung cancer (NSCLC) patients with brain metastasis (BM) and the factors impacting survival need to be assessed. METHODS: We retrospectively a...

Descripción completa

Detalles Bibliográficos
Autores principales: Higaki, Hajime, Nishioka, Kentaro, Otsuka, Manami, Nishikawa, Noboru, Shido, Motoyasu, Minatogawa, Hideki, Nishikawa, Yukiko, Takashina, Rikiya, Hashimoto, Takayuki, Katoh, Norio, Taguchi, Hiroshi, Kinoshita, Rumiko, Yasuda, Koichi, Mori, Takashi, Uchinami, Yusuke, Koizumi, Fuki, Fujita, Yoshihiro, Takahashi, Shuhei, Hattori, Takahiro, Nishiyama, Noriaki, Aoyama, Hidefumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903535/
https://www.ncbi.nlm.nih.gov/pubmed/36750899
http://dx.doi.org/10.1186/s13014-023-02218-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903535/
https://www.ncbi.nlm.nih.gov/pubmed/36750899
http://dx.doi.org/10.1186/s13014-023-02218-3

Ejemplares similares